This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Immunization Remove Process Improvement Related Topics
Compounding Pharmaceutical Companies Vaccines FDA Pharmaceutical Companies Hospitals More Related Topics >
article thumbnail

XtalPi and CK Life Sciences to develop AI-driven tumour vaccine R&D platform

Pharmaceutical Technology

NOVEMBER 25, 2022

The platform could potentially forecast and design several tumour vaccines that can trigger certain immune responses to fight tumours. Additionally, the platform could produce preclinical tumour vaccine candidate compounds with strong immune activity by incorporating algorithmic feedback to streamline activity and efficacy.

Vaccines 98
Vaccines Process Improvement Immunization Compounding 98
article thumbnail

Developing a first-in-class small molecule drug for inflammatory disease

European Pharmaceutical Review

NOVEMBER 9, 2023

TNF-alpha is an immune modulating cytokine whose dysregulation can lead to prolonged inflammatory responses and is known to drive disease in a range of autoimmune and inflammatory disorders. MYMD-1 has shown effectiveness in pre-clinical and clinical studies in regulating the immune system.

Pharmaceutical Companies 109
Pharmaceutical Companies Pharmaceutical Companies Immunization Process Improvement 109
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 18,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024